BCTXZ

BRIACELL THERAPEUTICS CORP.

BCTXZ · CIK 1610820 · Annual (10-K) · Last 4 years

Financial Trends

Revenue
20222025
Net Income−$26M
20222025
Operating CF−$28M
20222025
Free Cash Flow−$29M
20222025

Income Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕
Revenue————
Cost of Revenue————
Gross Profit————
R&D Expense$0.0B$0.0B$0.0B$0.0B
SG&A Expense————
Operating Income$-0.0B$-0.0B$-0.0B$-0.0B
Net Income$-0.0B$-0.0B$-0.0B$-0.0B
EPS (Basic)$-62.19$-0.29$-1.30$-1.73
EPS (Diluted)$-62.19$-0.29$-1.30—

Balance Sheet

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕
Total Assets$0.0B$0.0B$0.0B$0.0B
Current Assets$0.0B$0.0B$0.0B$0.0B
Cash & Equivalents$0.0B$0.0B$0.0B$0.0B
Total Liabilities————
Current Liabilities$0.0B$0.0B$0.0B$0.0B
Stockholders' Equity——$-0.0B$0.0B

Cash Flow Statement

MetricFY 2025↕FY 2024↕FY 2023↕FY 2022↕
Operating Cash Flow$-0.0B$-0.0B$-0.0B$-0.0B
Investing Cash Flow$-0.0B$-0.0B——
Capital Expenditures$0.0B$0.0B——
Financing Cash Flow$0.0B$0.0B$0.0B$-0.0B
← Companies